Introduction
Peripheral arterial disease and intermittent claudication (PAD-IC) refers to a chronic lowerlimb atherosclerotic disease that primarily affects the older population (1) . The disease negatively impacts on functional ability (2) , physical activity levels (3) and quality of life (4) . The most frequent site of claudication pain is in the plantarflexor (triceps surae) muscles (5) , where there are clear signs of dysfunction, such as reduced ankle power generation during gait (6, 7) .
However, the few previous studies directly investigating plantarflexor function are inconsistent about whether strength is diminished in claudicants compared to healthy controls (8) (9) (10) . Plantarflexor strength is a strong predictor of mortality in men with PAD-IC (11, 12) , so it is essential to understand the nature of any strength impairments and the underlying mechanisms, so that exercise interventions may be designed accordingly.
The "strength" of a muscle group, as measured externally by hand-held or isokinetic dynamometer, depends on numerous factors, including: muscle size and quality; voluntary activation level; any resistance to intended effort from co-activation of the antagonist muscle; and length of the moment arm about which the muscle is working (13) . Muscle quality during isometric contractions (often known as specific tension or specific force) is defined as the maximal potential muscle force (calculated using the above factors) normalised to the physiological cross-sectional area (13) . In PAD-IC voluntary joint moments have been measured previously (8) (9) (10) but the factors that determine externally-measured strength have not. Consequently, the underlying mechanisms explaining any disease-induced strength losses have not been identified, and muscle quality has not yet been quantified in claudicants.
Thus, it remains unknown if/how any deleterious changes in muscle properties contribute to reduced functional ability. Therefore, it is not apparent exactly how exercise interventions should be optimally designed to improve physical function.
Muscle quality is known to reduce with ageing and disuse (14) and increase in response to resistance training (15) . It is reasonable to assume muscle quality would be altered in claudicants given that the disease primarily affects the elderly (1) and is associated with reduced physical activity (3) . Additional factors associated with PAD-IC that may further affect muscle quality include intra-muscular fat infiltration (16) , which would reduce the quantity of contractile material within a given muscle, and altered fibre type composition, with contradicting findings of shifts towards more type II (fast-twitch) (17) (18) (19) and conversely to more type I fibres (slow-twitch) (20, 21) . As specific tension differs between fibre types (22) any changes at the fibre level may affect whole muscle quality, force producing potential and thus functional strength. If isometric muscle quality is altered with PAD-IC then it follows that the ability to utilise this force producing potential during dynamic contraction would also be impaired, especially if the proportion of fast type-II fibres is reduced. Any change in muscle quality might also reduce the responsiveness of muscles to exercise training, a vital component of treatment for PAD-IC (5) . This may contribute to the inconsistent effects reported following progressive resistance training in claudicants (23) .
The purpose of the study was to determine whether PAD-IC causes changes in the strength characteristics of the plantarflexors and quality of the gastrocnemii muscles. This was achieved by exploring relationships between static and dynamic measures of muscle quality and disease severity (as assessed through the ankle brachial pressure index; ABPI), and comparing asymptomatic and symptomatic limbs of claudicants to those of healthy controls.
To explore the effects of muscle quality on function, correlations were performed between the factors affecting muscle strength and walking endurance (quantified through initial and absolute claudication distances). Our first hypothesis was that increased disease severity would be associated with lower voluntary isometric plantarflexion moments and concentric plantarflexion powers, and that this would be explained by smaller muscle size and reduced static and dynamic muscle quality. Our second hypothesis was that walking endurance would be associated with reduced maximum isometric plantarflexion moment, concentric plantarflexion power, and static and dynamic muscle quality.
Methods

Participants
Ethical approval was granted by the National Health Service Research Ethics Committee (REC reference: 11/YH/0335). A total of 22 participants were recruited consisting of 12 claudicants (seven unilateral, five bilateral) and ten healthy controls (Table I) . Claudicants were recruited via consultant referral from a local outpatient vascular clinic. Male and female participants aged between 55-80 years who were diagnosed with Rutherford Grade 1 Chronic Limb Ischemia (24) with an arterial narrowing of the superficial femoral artery were considered for inclusion. Those with extensive disease were also included, however the primary stenosis identified using vascular imaging was located in the superficial femoral artery for all participants. Healthy controls were recruited from the local community via email and word of mouth. Individuals deemed to have severe or acute cardiovascular, musculoskeletal or pulmonary illness were excluded along with those with a previous lower-limb joint replacement. Any individuals with a history of neurological disorders, stroke, myocardial infarction or life-limiting diseases, such as cancer, were also excluded. All participants gave written informed consent prior to testing
Disease severity
Disease severity was determined using the ankle brachial pressure index/ratio (ABPI).
Systolic blood pressure was measured in the posterior tibial and dorsalis pedis arteries of each leg and the brachial pressure of both arms, separately, using a sphygmomanometer cuff and a hand held Doppler instrument (Parks Medical Electronics Inc, Oregon, USA). ABPI measures for both lower limbs were taken pre-and post-a standardised exercise protocol performed on a motorised treadmill (5minutes at 2.5km/h at 10% incline) (5) . Those unable to complete 5 minutes were able to stop at the point of maximum claudication pain. In accordance with standard protocol, the ABPI for both legs was then calculated as the higher of the two leg artery pressures normalised to the higher brachial pressure of the two arms (5) .
The post-exercise ABPI was subsequently used to categorise the limbs of the participants as well as classify disease severity. Any limb with an ABPI <0.9 was classified as claudicating and represents the 'claudicating-limb' group. The asymptomatic limb of the unilateral claudicants was identified (ABPI ≥0.9) and represents the 'asymptomatic-limb' group.
Control participants also undertook the exercise protocol to determine ABPI values, confirming the absence of PAD-IC.
Walking endurance
The 6-minute walk test was modified to be performed on level ground and combined with a pain rating based on the ACSM claudication pain scale (25) . This method is a reliable alternative to treadmill walk tests (26) and allows participants to walk for longer than 6-minutes if they are able. Patients walked continuously along a 10m walkway at a self-selected pace and informed the investigator of the level of pain and position on the pain scale every 20m.
Initial claudication distance was classed as level 1 on the pain scale and signified the onset of pain. Absolute claudication distance was classed as level 4 on the pain scale, represented maximal pain and signified the end of the test.
Experimental protocol
The static muscle quality (specific tension) of the combined gastrocnemii muscles was 2) Reduced gastrocnemii PCSA= (
where PCSA is physiological cross-sectional area, GL is lateral gastrocnemius, GM is medial gastrocnemius, V is muscle volume, FL is fascicle length and θ is pennation, both quantified during maximum voluntary contraction (MVC).
The methods used to determine each component of these equations are detailed below.
Measurements and calculations for maximal Achilles tendon force
Joint moment
Participants were secured into the chair of an isokinetic dynamometer (Biodex System 3, Biodex Medical Systems Inc, New York, USA), sat in an upright position with their hip flexed (85°), knee extended (0°) and the lateral malleolus aligned with the centre of rotation of the dynamometer arm during muscle contraction. To ensure isometric muscle strength of the gastrocnemii muscles was measured at the optimum joint angle, MVCs were elicited at 10° intervals from maximum plantarflexion to maximum dorsiflexion. Verbal encouragement was given throughout all trials. Three maximal isometric plantarflexion contractions were performed at each joint angle and the peak gravity corrected joint moment was taken forward for further analysis. For all participants, peak joint moment was achieved at maximum dorsiflexion, which was consistent with healthy populations (28) . All further trials to establish voluntary and antagonist activation, soleus contribution, fascicle length and pennation were performed in this joint position.
Antagonist co-activation
The contribution of antagonist muscle activity to the measured joint moment was estimated from the surface electromyography (EMG) (Telemyo 2400T, Noraxon, Arizona, USA) of the tibialis anterior, to represent the ankle dorsiflexors. Electrode placement and skin preparation were according to standardised guidelines (29) . The EMG of the tibialis anterior was recorded at 2000Hz synchronously with joint moments during the isometric plantarflexion contractions (working as an antagonist) and then combined with the EMG-moment relationship during dorsiflexion contractions (working as an agonist) to estimate the antagonist co-activation moment (27) .
Soleus contribution
The contribution of soleus to plantarflexion moment was quantified with additional plantarflexion contractions with the knee flexed where gastrocnemii muscle does not contribute to the measured joint moment (28) . Activation changes between the two positions were corrected using the EMG-moment relationship in two joint configurations using 
Measurement of moment arm length
Achilles tendon moment arm length was calculated using the tendon travel method (32) and using ultrasound imaging (50-mm probe length, MyLab50 x-vision, Esaote Biomedica, Genoa, Italy) to quantify linear myotendinous junction displacement.
Measures of muscle size at rest and architecture during MVC
Participants were asked to lie prone on a plinth with their ankle plantarflexed and supported on the bed with the musculature relaxed. To quantify lateral and medial gastrocnemius muscle volume, serial transverse ultrasound images of each muscle were overlaid to reconstruct a full anatomical cross-sectional area at 25, 50 and 75 % of muscle length.
Muscle volume was then calculated using the anatomical cross-sectional area's and muscle length by considering each muscle as two cones at either end of two truncated cones which is a reliable and valid alternative to MRI imaging (15) . Lateral and medial gastrocnemius volume were combined for total gastrocnemii muscle volume.
Optimum fascicle length and pennation angle during MVC were measured from synchronised sagittal-plane ultrasound video-recordings of the muscle belly of lateral and medial gastrocnemius , captured at 25Hz. The frame corresponding to peak tendon force was extracted for each muscle during three separate MVC trials and analysed in ImageJ (version 1.44, NIH, USA) (27) .
Measures of dynamic muscle quality
Isokinetic plantarflexion joint power was measured across the participants' full range of motion at angular velocities of 60, 90, 120 and 180 °/s in the same dynamometer set up described above. These velocities were selected to represent the range of joint speeds experienced during gait (33) . Five concentric contractions were performed at each velocity.
Peak power from each trial was recorded and the power-velocity profile constructed. The volume-normalised power-velocity relationship was established by normalising power at each velocity to gastrocnemii muscle volume, since the relative size of the gastrocnemii muscles and the soleus remain constant with ageing (34) . Dynamic muscle quality was defined as peak power normalised to gastrocnemii muscle volume. Adequate rest (>1 min) was provided between trials.
Statistical analysis
A linear relationship exists between advancing age and dynamic muscle quality (35) therefore a Pearson's partial product-moment correlation was performed to control for the influence of age and assess relationships between disease severity (as assessed by ABPI), walking endurance (as assessed by initial and absolute claudication distance) and gastrocnemii physiological cross-sectional area, volume and measures pertaining to static and dynamic muscle quality.
A one-way ANOVA was conducted to determine if significant between differences existed between the claudicating-limb and asymptomatic-limb groups and healthy controls. Data were assessed for normality,using Shapiro-Wilk's test for normality, and for outliers through box plot analysis. Sidak post-hoc was applied when appropriate. Mann-Whitney U tests were performed for non-parametric measures.
For all statistical tests, significance was accepted at P≤.05 and trends were accepted at P<.10.
For correlation and regression analyses, a moderate relationship was accepted as R=.40-.59, a strong relationship was accepted as R=.60-.79 and a very strong relationship was accepted as R=.80-1 (36) . Since low ABPI values indicate high disease severity a positive relationship indicates a decrease in the respective parameter with worsening disease.
Results
No significant differences were found between groups in height (P=.230) or mass (P=.167) (Table I) . Whilst age and gender were not exactly matched between groups, the between group age-difference (~5years) was not statistically significant and likely too small to have influenced our results (35) and there is no reason to believe gender differences influenced our measures of muscle quality (27) . Between-group differences in ABPI were consistent with disease presentation. One participant (unilateral claudicant) had type II diabetes that was being managed by diet intervention only. Inspection of this data, in comparison to the full claudicant cohort, revealed adaptations that were in keeping with those with similar ABPI values and of similar ages. We do not believe that, for this individual participant, diabetes was a confounding factor. (Table II) .
Shorter initial and absolute claudication distance were associated with larger gastrocnemii muscle volume, lower activation capacity and reduced dynamic muscle quality. Shorter absolute claudication distance was also correlated with reduced static muscle quality and shorter moment arm lengths (all R and p values are presented in Tables II and III) . Trends towards an association existed between shorter absolute claudication distance and reduced tendon force (P=.053) (Table II) . to healthy controls (P=.084) (Table IV) . Significant strength differences between claudicants and controls were apparent during higher 7 speed (≥120°/s) contractions. These data support our hypotheses that the dynamic muscle 8 quality of claudicants was reduced compared to healthy controls, and this was associated with 9 poorer walking endurance. These novel findings suggest that impaired muscle quality and a 10 greater reliance on the soleus muscle contribute to reduced dynamic strength of claudicants at 11 high speeds, which in turn contributes to the impaired functional ability seen in this 12 population. reported as a strong predictor of mortality in men with PAD-IC (11, 12) ; however the current data suggest that dynamic contractions at higher velocities may be more sensitive to 1 functional deteriorations, which was not apparent in previous sub-group analyses (37) . Future Some limitations to the present study must be acknowledged. It is recognised that the present 9 sample is small with a wide range of disease severity. Nonetheless we were able to detect 10 between-group differences and meaningful associations with walking endurance, as such we 11 consider this sample adequate to confirm the hypotheses. Static muscle quality should be 12 calculated with measures of truly optimal muscle force and length, i.e., plateau of the force-13 length relationship. As is typical for the plantarflexors, this plateau was not observed (28) and 14 we do not know whether participants reached optimal fascicle length. However, previous 15 work has shown that small changes in joint position do not significantly affect estimates of 16 muscle quality (27) . By calculating the quality of the entire gastrocnemii muscle group, errors 17 associated with distributing tendon force between the lateral and medial gastrocnemii 18 muscles were avoided. However, it was necessary to assume that once soleus contribution 19 was removed, the Achilles' tendon force reflected only that produced by the gastrocnemii 20 muscle. Dynamic muscle quality was calculated as plantarflexor joint power normalised to 21 gastrocnemii muscle volume only, assuming the relative size of these muscles remains 22 constant, as is the case in ageing (34) . Claudicants relied on the soleus more than healthy 23 controls did, meaning any error associated with this assumption will most likely 24 underestimate the true between-group difference in dynamic muscle quality. Additionally, moment arm length was determined during passive joint rotations at rest (32) and it is known to 1 change during contraction (40) . However, there is no reason to assume the change from rest to 2 contraction would be different between controls and claudicants; consequently, we consider 3 the comparisons presented in this study to remain valid.
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Conclusions
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The present study quantified the intrinsic quality of in vivo claudicant muscle for the first 7 time. Dynamic plantarflexion strength, particularly at the highest velocity, was lower in 8 claudicants compared to healthy controls and was significantly associated with disease 9 severity and impaired walking endurance. When dynamic strength was normalised to muscle 10 size (to calculate muscle quality) between group differences were larger and relationships 
